0.6393
price down icon0.87%   -0.0056
after-market Dopo l'orario di chiusura: .64 0.0007 +0.11%
loading
Precedente Chiudi:
$0.6449
Aprire:
$0.63
Volume 24 ore:
5.01M
Relative Volume:
0.90
Capitalizzazione di mercato:
$192.88M
Reddito:
$52.29M
Utile/perdita netta:
$-134.84M
Rapporto P/E:
-0.8524
EPS:
-0.75
Flusso di cassa netto:
$-117.11M
1 W Prestazione:
-4.91%
1M Prestazione:
+24.69%
6M Prestazione:
-9.40%
1 anno Prestazione:
-31.68%
Intervallo 1D:
Value
$0.6114
$0.65
Intervallo di 1 settimana:
Value
$0.60
$0.7191
Portata 52W:
Value
$0.4111
$3.179

Sangamo Therapeutics Inc Stock (SGMO) Company Profile

Name
Nome
Sangamo Therapeutics Inc
Name
Telefono
(510) 970-6000
Name
Indirizzo
501 CANAL BLVD., RICHMOND, CA
Name
Dipendente
183
Name
Cinguettio
@sangamotx
Name
Prossima data di guadagno
2025-05-02
Name
Ultimi documenti SEC
Name
SGMO's Discussions on Twitter

Confronta SGMO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SGMO
Sangamo Therapeutics Inc
0.6393 194.57M 52.29M -134.84M -117.11M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-13 Aggiornamento Truist Hold → Buy
2024-12-10 Reiterato H.C. Wainwright Buy
2023-11-03 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-04-28 Downgrade BofA Securities Neutral → Underperform
2023-02-27 Aggiornamento Wedbush Neutral → Outperform
2023-01-06 Downgrade BofA Securities Buy → Neutral
2022-06-13 Ripresa Wedbush Neutral
2021-05-04 Iniziato RBC Capital Mkts Outperform
2021-01-07 Ripresa Guggenheim Neutral
2021-01-06 Iniziato Stifel Hold
2020-12-16 Ripresa H.C. Wainwright Buy
2020-09-08 Iniziato BofA Securities Buy
2020-07-07 Iniziato SunTrust Buy
2019-08-26 Iniziato H.C. Wainwright Buy
2018-11-14 Downgrade JP Morgan Overweight → Neutral
2018-11-09 Downgrade Guggenheim Buy → Neutral
2018-10-10 Iniziato Guggenheim Buy
2018-06-20 Iniziato BofA/Merrill Buy
2017-11-15 Aggiornamento Piper Jaffray Neutral → Overweight
2017-06-22 Ripresa Jefferies Buy
2016-11-01 Downgrade Wedbush Outperform → Neutral
2016-10-19 Downgrade Piper Jaffray Overweight → Neutral
2015-12-04 Iniziato Wells Fargo Outperform
2015-10-23 Ripresa Jefferies Buy
2013-05-03 Iniziato BioLogic Equity Research Sell
2011-02-23 Reiterato JMP Securities Mkt Outperform
2010-07-29 Reiterato Wedbush Outperform
2009-10-19 Iniziato Brean Murray Sell
2009-10-07 Reiterato Leerink Swann Outperform
2009-08-25 Reiterato JMP Securities Mkt Outperform
Mostra tutto

Sangamo Therapeutics Inc Borsa (SGMO) Ultime notizie

pulisher
Oct 18, 2025

Is Sangamo Therapeutics Inc. stock ready for a breakoutEarnings Risk Summary & Community Verified Watchlist Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Combining machine learning predictions for Sangamo Therapeutics Inc.IPO Watch & Fast Moving Market Watchlists - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Is Sangamo Therapeutics Inc. stock in correction or buying zoneTrade Exit Report & Technical Entry and Exit Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Will Sangamo Therapeutics Inc. stock split again soon2025 Technical Overview & Free Community Consensus Stock Picks - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025
pulisher
Oct 17, 2025

What machine learning models say about Sangamo Therapeutics Inc.Options Play & Real-Time Volume Trigger Notifications - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Short Squeeze: What hedge fund activity signals for Sangamo Therapeutics Inc. stockJuly 2025 Opening Moves & Safe Entry Momentum Tips - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

Is Sangamo Therapeutics Inc. (GBY) stock positioned for secular growthJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 17, 2025
pulisher
Oct 17, 2025

How Sangamo Therapeutics Inc. stock reacts to bond yieldsJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com

Oct 17, 2025
pulisher
Oct 16, 2025

What analyst consensus says on Sangamo Therapeutics Inc. stockMarket Movement Recap & High Conviction Buy Zone Alerts - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Multi factor analysis applied to Sangamo Therapeutics Inc.Weekly Earnings Recap & Low Risk High Win Rate Stock Picks - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Published on: 2025-10-14 00:29:18 - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Is Sangamo Therapeutics Inc. (GBY) stock a fit for income portfolios2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Combining price and volume data for Sangamo Therapeutics Inc.2025 Market Overview & Low Risk Growth Stock Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-12 23:29:27 - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Will earnings trigger a reversal in Sangamo Therapeutics Inc.Entry Point & Free Verified High Yield Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Sangamo Therapeutics (NASDAQ:SGMO) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Volume spikes in Sangamo Therapeutics Inc. stock – what they meanWeekly Investment Summary & Community Consensus Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

What analysts say about Sangamo Therapeutics Inc stockAnalyst Upgrades & Compound Your Gains With Quality Stocks - earlytimes.in

Oct 08, 2025
pulisher
Oct 07, 2025

There's No Escaping Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Muted Revenues Despite A 28% Share Price Rise - simplywall.st

Oct 07, 2025
pulisher
Oct 06, 2025

Visual trend scoring systems applied to Sangamo Therapeutics Inc.Weekly Profit Summary & Step-by-Step Swing Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Published on: 2025-10-06 03:38:37 - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Sangamo Therapeutics Inc. (GBY) stock stays on buy listsEarnings Miss & Weekly Breakout Stock Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Sangamo Therapeutics Inc. (GBY) stock a good hedge against inflationWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 05:08:49 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What hedge fund activity signals for Sangamo Therapeutics Inc. stock2025 Price Targets & High Return Stock Watch Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 02:36:48 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 07:10:00 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to monitor Sangamo Therapeutics Inc. with trend dashboards2025 Performance Recap & Fast Entry High Yield Tips - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Why Sangamo Therapeutics Inc. (GBY) stock stays resilientEarnings Miss & Expert Verified Movement Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 02, 2025

Sangamo Therapeutics Inc Azioni (SGMO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):